Treatment and Intervention

An open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence

image - CoLAB

Retaining patients in buprenorphine treatment is essential in maximising treatment outcomes and minimising mortality risk. Delivery of treatment via novel depot buprenorphine products has the potential to enhance patient adherence and retention in treatment.

Project Status: 
Current

Behavioural activation therapy for the treatment of co-occurring depression and opioid dependence

image - 1338942619 Group Therapy Chairs 280

Heroin dependence is a chronic relapsing condition, associated with high levels of psychopathology. On entry to treatment approximately one quarter of heroin users meet criteria for Major Depression (MD), and this comorbidity has been linked to poorer treatment outcomes.

Project Status: 
Completed

Increasing the capacity of community pharmacy for screening, brief intervention and referral for treatment of pharmaceutical opioid use disorders

image - Prescription 280l 1

This translational research project will embed screening, brief intervention and referral into community pharmacy practice, in addition to establishing clear referral pathways with primary, secondary and tertiary treatment service

Project Status: 
Current

Exploration of partnerships between rural Aboriginal communities and researchers to prevent and treat drug and alcohol-related harms: Three examples in remote NSW

image - Aboriginal Women Square Copy

This project seeks to develop knowledge about effective models of partnership between rural Aboriginal communities and researchers across a range of community-led programs delivered from 2012-2016, which aimed to reduce drug and alcohol-related harm.

Project Status: 
Current